Form 4 Filing for Gary P. Fischetti - Anika Therapeutics, Inc.

Gary P. Fischetti, a director at Anika Therapeutics, Inc., acquired 10,402 shares of common stock on June 18, 2026. This acquisition was part of a restricted stock unit (RSU) grant, with each RSU representing a contingent right to one share of common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of stockholders or June 18, 2027. Following this transaction, Mr. Fischetti now owns 52,015 shares of common stock. The transaction code "A" indicates an acquisition, and the price per share was $0, consistent with the nature of an RSU grant. The filing was made on June 23, 2026.